BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1722754)

  • 1. Muscarinic receptor agonist-mediated modulation of neuronal activity in rat cerebral cortex.
    Lin Y; Phillis JW
    Eur J Pharmacol; 1991 Jul; 200(1):45-52. PubMed ID: 1722754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic agonist oxotremorine-M-induced long-term depression in rat cerebral cortex.
    Lin Y; Phillis JW
    Brain Res Bull; 1991 Jul; 27(1):115-7. PubMed ID: 1682019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimuscarinic potency and functional selectivity of oxotremorine analogs at muscarinic receptor subtypes in the rat.
    Vargas HM; Ringdahl B
    Life Sci; 1990; 47(22):2065-73. PubMed ID: 1703260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct muscarinic receptor subtypes differentially modulate acetylcholine release from corticocerebral synaptosomes.
    Pittel Z; Heldman E; Rubinstein R; Cohen S
    J Neurochem; 1990 Aug; 55(2):665-72. PubMed ID: 1695243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic suppression of the evoked N-wave by oxotremorine-M recorded in the guinea-pig olfactory cortex slice.
    Bagetta G; Constanti A
    Eur J Pharmacol; 1990 Mar; 178(1):91-6. PubMed ID: 2332031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of M1-muscarinic receptors in the excitation of neocortical neurones by acetylcholine.
    Bradshaw CM; Sheridan RD; Szabadi E
    Neuropharmacology; 1987 Aug; 26(8):1195-200. PubMed ID: 2443871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic agonist-mediated induction of long-term potentiation in rat cerebral cortex.
    Lin Y; Phillis JW
    Brain Res; 1991 Jun; 551(1-2):342-5. PubMed ID: 1680527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of muscarinic agonists in rat superior cervical ganglion and hippocampal slices.
    Boddeke HW
    Eur J Pharmacol; 1991 Aug; 201(2-3):191-7. PubMed ID: 1724649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of specific M1, M2 muscarinic receptor agonists on REM sleep generation.
    Velazquez-Moctezuma J; Gillin JC; Shiromani PJ
    Brain Res; 1989 Nov; 503(1):128-31. PubMed ID: 2482113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic receptor subtypes and sexual behavior in female rats.
    Dohanich GP; McMullan DM; Cada DA; Mangum KA
    Pharmacol Biochem Behav; 1991 Jan; 38(1):115-24. PubMed ID: 1708147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
    Gil DW; Wolfe BB
    J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C; el-Fakahany EE
    Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional differences in the coupling of muscarinic receptors to inositol phospholipid hydrolysis in guinea pig brain.
    Fisher SK; Bartus RT
    J Neurochem; 1985 Oct; 45(4):1085-95. PubMed ID: 2411866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of presynaptic muscarinic receptors involved in modulation of transmitter release.
    Vizi ES; Kobayashi O; Töröcsik A; Kinjo M; Nagashima H; Manabe N; Goldiner PL; Potter PE; Foldes FF
    Neuroscience; 1989; 31(1):259-67. PubMed ID: 2549449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermic response of selective muscarinic agonists and antagonists in rat.
    Sen AP; Bhattacharya SK
    Indian J Exp Biol; 1991 Feb; 29(2):131-5. PubMed ID: 1869296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
    McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
    Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic M2-muscarinic receptors on noradrenergic nerve endings and endothelium-derived M3 receptors in cat cerebral arteries.
    Alonso MJ; Arribas S; Marín J; Balfagón G; Salaices M
    Brain Res; 1991 Dec; 567(1):76-82. PubMed ID: 1726141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.
    Haddad EB; Landry Y; Gies JP
    Mol Pharmacol; 1990 May; 37(5):682-8. PubMed ID: 1692606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
    Moroi-Fetters SE; Neff NH; Hadjiconstantinou M
    J Pharmacol Exp Ther; 1988 Aug; 246(2):553-7. PubMed ID: 2841451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.